AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol - Wikidata - awgldk - TriplyDB

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

http://www.wikidata.org/entity/Q33688533

about

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics The endothelium abridges insulin resistance to premature aging Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR AMP-activated protein kinase, stress responses and cardiovascular diseases The AMPK signalling pathway coordinates cell growth, autophagy and metabolism Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 Resveratrol Inhibition of Cellular Respiration: New Paradigm for an Old Mechanism Sirt1 and the Mitochondria Mitochondria: a new therapeutic target in chronic kidney disease An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol Mitochondrial targets for pharmacological intervention in human disease Sirtuin 1 and sirtuin 3: physiological modulators of metabolism Sirtuins as regulators of metabolism and healthspan SIRT1 as a therapeutic target in inflammaging of the pulmonary disease Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies Diabetic complications in pregnancy: is resveratrol a solution?Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy Phytochemicals as novel agents for the induction of browning in white adipose tissue Natural Compounds Modulating Mitochondrial Functions Mediation of endogenous antioxidant enzymes and apoptotic signaling by resveratrol following muscle disuse in the gastrocnemius muscles of young and old rats Dietary antiaging phytochemicals and mechanisms associated with prolonged survival Mitochondrial dysfunction in neurodegenerative diseases Arctigenin efficiently enhanced sedentary mice treadmill endurance Resveratrol inhibits protein translation in hepatic cells Resveratrol modulates mitochondria dynamics in replicative senescent yeast cells Resveratrol Enhances Neuroplastic Changes, Including Hippocampal Neurogenesis, and Memory in Balb/C Mice at Six Months of Age LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Dietary Factors Promoting Brown and Beige Fat Development and Thermogenesis.Treatment of nonalcoholic fatty liver disease: role of AMPK.Resveratrol attenuated estrogen-deficient-induced cardiac dysfunction: role of AMPK, SIRT1, and mitochondrial function.Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice

P2860

Q21089966-96BBF8DF-4BCC-420F-8633-3A1726980C71 Q24562914-EDD01AE8-0E7C-4D1C-AFE2-F12585458740 Q24605364-C57C87BB-2119-4B32-A2AE-8BCB7F1C53EF Q24608197-981C21D7-F3E8-4192-9F21-566B73629F2D Q24608321-3A61BFFD-FA71-456B-A4EB-520AD42B64A0 Q24610297-24B1698B-819C-4267-ACD9-C354F8F162BC Q24616273-FB0C70B9-225A-49FD-B53B-21C71F8706B8 Q24618313-066D13E1-58BA-4BA9-82F1-1CD7A789E18F Q24633063-E4787D79-CE74-4112-B920-1C620F0BFF56 Q26753034-2CF19163-FBF5-44B7-8724-5C55D6BF9B00 Q26772894-3C91B3F1-6C56-470D-9A67-A89ADCA20317 Q26776397-C324943D-3218-48E2-B7FD-AE5CBF570706 Q26800907-7E048AF1-B675-4BB0-8854-9AEA7B26855B Q26824514-D64693FD-73F2-43B6-9140-8CB2DDE77B26 Q26828607-382D0448-9105-432A-A829-CCF6C5A32CE5 Q26828939-B6EDB219-CECB-4D40-B953-FEA4310E9684 Q26829351-29BBC7A8-9615-4502-AA75-93F658979365 Q26864685-11A31045-4D93-469C-AC95-410628F354BC Q26865526-C44EB1D2-84F7-400B-99F2-2569F58D3243 Q27002459-31E958ED-47C8-4C84-9832-223F63C29D0B Q27012844-D0B85F1E-54FF-4ACF-96C8-60E7540560C9 Q27316203-C7E9F7FD-56A8-41DF-8CDC-4C39EA77CFD2 Q27338799-08C2D2BE-5161-4E27-872F-E39547D4ACC0 Q28068120-4E77D8FC-9C92-4E44-B450-4B39A92691C1 Q28073857-6766949E-8C4A-48CC-B59E-A9C3829B4995 Q28087261-2F97E2D2-C5F4-4303-A2BD-7C166B4160A3 Q28385398-6EBB38A0-6A11-4595-A1BD-7C71D4EFC6D2 Q28385788-85312418-4024-4FA3-81A0-BA49BACD97A3 Q28387647-0E83038F-F750-4FC0-96C7-D6D824CF11A3 Q28476727-4E0D67E2-E410-485D-9733-7DD3984D0139 Q28478644-1B233EA8-32F6-4DE6-B197-819D5955520C Q28541658-D831B959-C56A-430F-A79B-E25AE5478CE6 Q28551780-C0EEC418-57AA-49E8-BD13-C8C0E4B8A9AB Q28552277-8ABCA3A4-B1AF-4E4C-8F89-42637AAA29A3 Q28566837-7C2B12C1-2BF5-4BE4-9A5F-73976AEDB61F Q28591122-9BE105A5-75BC-4F1C-A93B-1D3C8067E9B5 Q30234449-1C60E472-5467-4574-A7BD-B53DE6496EC2 Q30248230-3F77BE28-E906-46D9-8CD5-5AB5D331B2ED Q30379511-3F2FD15C-9055-4727-96CF-DAC72635879D Q30423466-9B13AC2E-0B56-4F79-8FEC-1EA764E3A2E6

P2860

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

http://www.wikidata.org/entity/Q33688533

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@ast

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@en

type

label

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@ast

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@en

prefLabel

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@ast

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@en

P1433

Q33688533-C29A8E39-A7AC-4E22-A06A-C8C273542113

P1476

Q33688533-F12AAA10-2EA6-46D8-B251-12CDF4A34661

P2093

Q33688533-0D11D8B1-4F87-4E65-A8F9-248CB3B5D46A

Q33688533-2783F945-6F66-4DA1-B99D-132F0C963CC1

Q33688533-35FF923F-A3DD-497D-8F7E-8E1FBE717552

Q33688533-41DC45C6-6FB4-4142-8D47-52983CE0C0B0

Q33688533-940B2A72-1B84-46B6-BFA8-8D1429A63862

Q33688533-B6B671CC-6015-4A09-9EE4-5A88745859DC

Q33688533-C7691829-183B-42B0-A3B5-C4BB445AEAC6

P2860

Q33688533-0199F996-C28E-4CA7-AA0F-6028AE61475A

Q33688533-0DABDB06-D23E-4F98-BF8D-DB377F187F27

Q33688533-13B9B9B1-B288-4C42-9023-0A3C2294B95C

Q33688533-1A0E55D6-793A-44B3-9692-FE641C43177F

Q33688533-22421B78-AE86-447D-BD02-36D80702ABBF

Q33688533-24B881C7-5409-4EC2-8AEC-9127AA752003

Q33688533-275D4D70-23C8-45CF-9412-DAD002875384

Q33688533-29B9A6B6-9081-426E-ABE6-3210D57E6B35

Q33688533-2ECDB386-4FC3-4E19-A9F2-4D983DB8DA6D

Q33688533-2FAA8FB2-C7D1-4DBE-8F22-76482F0BE681

P304

Q33688533-C2917D66-B141-4C97-B088-4AD23CFC3C92

P31

Q33688533-A471A773-F3F0-4CDA-B7B9-3D44B6B62F47

P356

Q33688533-360CFF85-31F1-458D-8A86-0DCB08B02B71

P407

Q33688533-836ACCEB-306C-469C-B83A-AB4E2EEA5A4D

P433

Q33688533-29922B8E-15C0-4643-8DE3-A663A6D3323A

P478

Q33688533-5979C78E-1946-4C97-8A0C-5665801CA448

P50

Q33688533-0DE7E7F7-BCE9-41F3-9E10-0A03C3CFA071

Q33688533-F2B220CC-38B4-405B-95B0-0D1236C4CFFA

P577

Q33688533-4426CD75-68B7-4021-8BEF-FA98EE3F6AC4

P5875

Q33688533-BCD49361-49A7-47AE-A6BA-F333673F90B7

P698

Q33688533-FEC16B09-B7FC-47C7-9D5A-EAAF8D1DE830

P932

Q33688533-9336D478-464C-4AB9-BA1D-C1324A0EA60C

P356

P1433

P1476

AMP-activated protein kinase-d ...... tabolic effects of resveratrol

@en

P2093

Hyeog Kang

http://www.w3.org/2001/XMLSchema#string

Jay H Chung

http://www.w3.org/2001/XMLSchema#string

Jee-Hyun Um

http://www.w3.org/2001/XMLSchema#string

Michael W McBurney

http://www.w3.org/2001/XMLSchema#string

Myung K Kim

http://www.w3.org/2001/XMLSchema#string

Shutong Yang

http://www.w3.org/2001/XMLSchema#string

Sung-Jun Park

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Mammalian AMP-activated protein kinase subfamily

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis

AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

P304

554-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB09-0482

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40027357

http://www.w3.org/2001/XMLSchema#string

P698

19934007

http://www.w3.org/2001/XMLSchema#string

P932

2828647

http://www.w3.org/2001/XMLSchema#string